MSI-78

DRUG2 trials

Sponsors

Abeona Therapeutics, Inc

Conditions

Diabetic Foot Ulcers

Phase 3

MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers

CompletedNCT00563433

Abeona Therapeutics, IncDiabetic Foot Ulcers

Start: 1994-08-31End: 1996-07-31Updated: 2020-09-03

MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers

CompletedNCT00563394

Abeona Therapeutics, IncDiabetic Foot Ulcers

Start: 1994-08-31End: 1996-07-31Updated: 2020-09-03

Related Papers

Antibacterial Activity of Surfactin and Synergistic Effect with Conventional Antibiotics Against Methicillin-Resistant Staphylococcus Aureus Isolated from Patients with Diabetic Foot Ulcers [Response to Letter]

Diabetes Metabolic Syndrome and Obesity2023-12-011 citations